SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nishi Mody, Surbhi Dubey, Rajeev Sharma, Udita Agrawal, Suresh P Vyas, Dendritic cell-based vaccine research against cancer, Expert Review of Clinical Immunology, 2015, 11, 2, 213

    CrossRef

  2. 2
    Halmurat Upur, Yin Chen, Mayila Kamilijiang, Wanli Deng, Xierzhatijiang Sulaiman, Renaguli Aizezi, Xiao Wu, Wuniqiemu Tulake, Abulizi Abudula, Identification of plasma protein markers common to patients with malignant tumour and Abnormal Savda in Uighur medicine: a prospective clinical study, BMC Complementary and Alternative Medicine, 2015, 15, 1, 9

    CrossRef

  3. 3
    Rivka Ben Ishay, Yaara Kapp-Barnea, Irena Grigoriantz, Eti Teblum, Jean-Paul Lellouche, Real time acoustic profiling of a live cancerous cell monolayer using QCM, Sensors and Actuators B: Chemical, 2015, 215, 373

    CrossRef

  4. 4
    Christoph Schröder, Harish Srinivasan, Martin Sill, Jakob Linseisen, Kurt Fellenberg, Nikolaus Becker, Alexandra Nieters, Jörg D. Hoheisel, Plasma protein analysis of patients with different B-cell lymphomas using high-content antibody microarrays, PROTEOMICS - Clinical Applications, 2013, 7, 11-12
  5. 5
    Nina Kočevar, Petra Hudler, Radovan Komel, The progress of proteomic approaches in searching for cancer biomarkers, New Biotechnology, 2013, 30, 3, 319

    CrossRef

  6. 6
    Peter Findeisen, Michael Neumaier, Functional protease profiling for diagnosis of malignant disease, PROTEOMICS - Clinical Applications, 2012, 6, 1-2
  7. 7
    Anne K. Callesen, Ole Mogensen, Andreas K. Jensen, Torben A. Kruse, Torben Martinussen, Ole N. Jensen, Jonna S. Madsen, Reproducibility of mass spectrometry based protein profiles for diagnosis of ovarian cancer across clinical studies: A systematic review, Journal of Proteomics, 2012, 75, 10, 2758

    CrossRef

  8. 8
    Brian Casserly, Richard Read, Mitchell M. Levy, Multimarker Panels in Sepsis, Critical Care Clinics, 2011, 27, 2, 391

    CrossRef

  9. 9
    Piotr Waloszczyk, Tomasz Janus, Jacek Alchimowicz, Tomasz Grodzki, Krzysztof Borowiak, Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material, Diagnostic Pathology, 2011, 6, 1, 22

    CrossRef

  10. 10
    Chiara Fania, Michele Vasso, Enrica Torretta, Paul Robach, Gaetano Cairo, Carsten Lundby, Cecilia Gelfi, Setup for human sera MALDI profiling: The case of rhEPO treatment, ELECTROPHORESIS, 2011, 32, 13
  11. 11
    M.A. Karpova, S.A. Moshkovskii, I.Y. Toropygin, A.I. Archakov, Cancer-specific MALDI-TOF profiles of blood serum and plasma: Biological meaning and perspectives, Journal of Proteomics, 2010, 73, 3, 537

    CrossRef

  12. 12
    C. Colussi, C. Banfi, M. Brioschi, E. Tremoli, S. Straino, F. Spallotta, Antonello Mai, Dante Rotili, M. C. Capogrossi, Carlo Gaetano, Proteomic profile of differentially expressed plasma proteins from dystrophic mice and following suberoylanilide hydroxamic acid treatment, PROTEOMICS - Clinical Applications, 2010, 4, 1
  13. 13
    Petra Hudler, Masa Gorsic, Radovan Komel, Proteomic strategies and challenges in tumor metastasis research, Clinical & Experimental Metastasis, 2010, 27, 6, 441

    CrossRef

  14. 14
    Sei Hoon Yang, Biomarkers for Lung Cancer, Journal of Lung Cancer, 2009, 8, 2, 67

    CrossRef

  15. 15
    Yujun He, Zhirong Mou, Wanlin Li, Baohua Liu, Tao Fu, Shong Zhao, Debing Xiang, Yuzhang Wu, Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis, International Journal of Colorectal Disease, 2009, 24, 11, 1271

    CrossRef

  16. 16
    Peter Findeisen, Michael Neumaier, Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective, Clinical Chemistry and Laboratory Medicine, 2009, 47, 6

    CrossRef

  17. 17
    Hari R Kumar, Xiaoling Zhong, Frederick J Rescorla, Robert J Hickey, Linda H Malkas, John A Sandoval, Proteomic approaches in  neuroblastoma: a  complementary clinical platform for the future, Expert Review of Proteomics, 2009, 6, 4, 387

    CrossRef

  18. 18
    Chi-Li Chiu, Sarah Randall, Mark P Molloy, Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis, Bioanalysis, 2009, 1, 4, 847

    CrossRef

  19. 19
    Anne K. Callesen, Jonna S. Madsen, Werner Vach, Torben A. Kruse, Ole Mogensen, Ole N. Jensen, Serum protein profiling by solid phase extraction and mass spectrometry: A future diagnostics tool?, PROTEOMICS, 2009, 9, 6
  20. 20
    Ahmed O. Kaseb, Amr Hanbali, Matthew Cotant, Manal M. Hassan, Ira Wollner, Philip A. Philip, Vascular endothelial growth factor in the management of hepatocellular carcinoma, Cancer, 2009, 115, 21
  21. 21
    Hye-Jin Sung, Je-Yoel Cho, Biomarkers for the lung cancer diagnosis and their advances in proteomics, BMB Reports, 2008, 41, 9, 615

    CrossRef

  22. 22
    Lene Alsøe, John Erik Stacy, Alexander Fosså, Steinar Funderud, Ole Henrik Brekke, Gustav Gaudernack, Identification of prostate cancer antigens by automated high-throughput filter immunoscreening, Journal of Immunological Methods, 2008, 330, 1-2, 12

    CrossRef

  23. 23
    Shaohui Sui, Jinglan Wang, Bing Yang, Lina Song, Jiyang Zhang, Ming Chen, Jinfeng Liu, Zhuang Lu, Yun Cai, Shuo Chen, Wei Bi, Yunping Zhu, Fuchu He, Xiaohong Qian, Phosphoproteome analysis of the human Chang liver cells using SCX and a complementary mass spectrometric strategy, PROTEOMICS, 2008, 8, 10
  24. 24
    Peter Findeisen, Teresa Peccerella, Michael Neumaier, Dirk Schadendorf, Proteomics for biomarker discovery in malignant melanoma, Expert Review of Dermatology, 2008, 3, 2, 209

    CrossRef

  25. 25
    Lello Zolla, Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins, Drug Discovery Today, 2008, 13, 23-24, 1042

    CrossRef

  26. 26
    Richard J Simpson, Oliver K Bernhard, David W Greening, Robert L Moritz, Proteomics-driven cancer biomarker discovery: looking to the future, Current Opinion in Chemical Biology, 2008, 12, 1, 72

    CrossRef

  27. 27
    Suzanne Smit, Huub C.J. Hoefsloot, Age K. Smilde, Statistical data processing in clinical proteomics, Journal of Chromatography B, 2008, 866, 1-2, 77

    CrossRef

  28. 28
    P. Schubert, D. V. Devine, The application of proteomics to blood banking, ISBT Science Series, 2008, 3, 1
  29. 29
    Yetrib Hathout, Approaches to the study of the cell secretome, Expert Review of Proteomics, 2007, 4, 2, 239

    CrossRef

  30. 30
    Connie R Jimenez, Sander Piersma, Thang V Pham, High-throughput and targeted in-depth mass spectrometry-based approaches for biofluid profiling and biomarker discovery, Biomarkers in Medicine, 2007, 1, 4, 541

    CrossRef

  31. 31
    Carl AK Borrebaeck, Christer Wingren, High-throughput proteomics using antibody microarrays: an update, Expert Review of Molecular Diagnostics, 2007, 7, 5, 673

    CrossRef

  32. 32
    Xuewu Zhang, Dong Wei, Yeeleng Yap, Lin Li, Siyuan Guo, Feng Chen, Mass spectrometry-based “omics” technologies in cancer diagnostics, Mass Spectrometry Reviews, 2007, 26, 3
  33. 33
    Edita Aksamitiene, Jan B. Hoek, Boris Kholodenko, Anatoly Kiyatkin, Multistrip Western blotting to increase quantitative data output, ELECTROPHORESIS, 2007, 28, 18
  34. 34
    William CS Cho, Christopher HK Cheng, Oncoproteomics: current trends and future perspectives, Expert Review of Proteomics, 2007, 4, 3, 401

    CrossRef

  35. 35
    Li-Rong Yu, Haleem J. Issaq, Timothy D. Veenstra, Phosphoproteomics for the discovery of kinases as cancer biomarkers and drug targets, PROTEOMICS - Clinical Applications, 2007, 1, 9
  36. 36
    Christer Wingren, Carl A.K. Borrebaeck, Progress in miniaturization of protein arrays—a step closer to high-density nanoarrays, Drug Discovery Today, 2007, 12, 19-20, 813

    CrossRef

  37. 37
    Vladimir Brusic, Ovidiu Marina, Catherine J. Wu, Ellis L. Reinherz, Proteome informatics for cancer research: From molecules to clinic, PROTEOMICS, 2007, 7, 6
  38. 38
    Ashima Sinha, Chetna Singh, Devendra Parmar, Mahendra Pratap Singh, Proteomics in clinical interventions: Achievements and limitations in biomarker development, Life Sciences, 2007, 80, 15, 1345

    CrossRef

  39. 39
    María Pardo, Raymond A Dwek, Nicole Zitzmann, Proteomics in uveal melanoma research: opportunities and challenges in biomarker discovery, Expert Review of Proteomics, 2007, 4, 2, 273

    CrossRef

  40. 40
    Adekunle I. Elegbede, Manas K. Haldar, Sumathra Manokaran, Sanku Mallik, D. K. Srivastava, Recognition of isozymes via lanthanide ion incorporated polymerized liposomes, Chemical Communications, 2007, 43, 4495

    CrossRef

  41. 41
    Gilbert S. Omenn, THE HUPO Human Plasma Proteome Project, PROTEOMICS - Clinical Applications, 2007, 1, 8
  42. 42
    André Schrattenholz, Karlfried Groebe, What does it need to be a biomarker? Relationships between resolution, differential quantification and statistical validation of protein surrogate biomarkers, ELECTROPHORESIS, 2007, 28, 12